Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-Cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-Deficient Meningioma Growth

Cancer Research - United States
doi 10.1158/0008-5472.can-12-1888
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Novel Γ-Lactam-Based Histone Deacetylase Inhibitor Potently Inhibits the Growth of Human Breast and Renal Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Histone Deacetylase Inhibitor Upregulates Peroxisomal Fatty Acid Oxidation and Inhibits Apoptotic Cell Death in Abcd1-Deficient Glial Cells

PLoS ONE
Multidisciplinary
2013English

Molecular Cytogenetic Study of the Nf2 Gene Deletion in Meningioma in Sudanese Patients

Balkan Journal of Medical Genetics
Genetics
2013English

Meningioma

2020English

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Incidental Meningioma

Neurologia Medico-Chirurgica
SurgeryNeurology
1985English

Extracranial Meningioma

English

Atypical Growth Pattern of an Intraparenchymal Meningioma

Case Reports in Radiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy